Junhu Li

Junhu Li

Auto-generated profile, based on publicly available information

Junhu Li

Department of Nephrology Shanxi Provincial People's Hospital Taiyuan Shanxi China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
YLYuanyuan Lin
Yuanyuan Lin
JLJunhu Li
Junhu Li
BZBaozhong Zhu
Baozhong Zhu
QLQinghua Liu
Qinghua Liu
XBXiao-jie Bai
Xiao-jie Bai
DWDe-Ping Wang
De-Ping Wang
Background: Zacopride, a potent antagonist of 5-HT3 receptors and an agonist of 5-HT4 receptors, is a gastrointestinal prokinetic agent. In a previous study, we discovered that zacopride selectively stimulated the inward rectifier potassium current (IK1) in the rat and that agonizing IK1 prevented or eliminated aconitine-induced arrhythmias in rats. Objective: Our aims were to confirm that the antiarrhythmic effects of zacopride are mediated by selectively enhancing IK1 in rabbits. Methods: The effects of zacopride on the function of the main ion channels were investigated using a whole-cell patch-clamp technique in rabbits. Effects of zacopride on cardiac arrhythmias were also explored experimentally both in vivo and in vitro. Results: Zacopride moderately enhanced cardiac IK1 but had no apparent action on voltage-gated sodium current (INa), L- type calcium current (ICa-L), sodium-calcium exchange current (INa/Ca), transient outward potassium current (Ito), or delayed rectifier potassium current (IK) in rabbits. Zacopride also had a marked antiarrhythmic effect in vivo and in vitro. We proved that the resting membrane potential (RMP) was hyperpolarized in the presence of 1 μmol/L zacopride, and the action potential duration (APD) at 90% repolarization (APD90) was shortened by zacopride (0.1-10 μmol/L) in a concentration- dependent manner. Furthermore, zacopride at 1 μmol/L significantly decreased the incidence of drug-induced early afterdepolarization (EAD) in rabbit ventricular myocytes. Conclusion: Zacopride is a selective agonist of rabbit cardiac IK1 and that IK1 enhancement exerts potential antiarrhythmic effects.

26 October 2026 in Cell Biochemistry and Function
Verified
Journal Article
Open access
PDF file
LXLuming Xi
Luming Xi
MBMengqi Bai
Mengqi Bai
JLJunhu Li
Junhu Li
ZZZhibo Zhao
Zhibo Zhao
XZXiaoshuang Zhou
Xiaoshuang Zhou
Cordycepin (COR) exerts pharmacological effects in various diseases, yet its role in tissue repair following acute kidney injury (AKI) remains to be fully elucidated. This study aimed to investigate whether COR delays the progression from acute kidney injury to chronic kidney disease (AKI‐CKD) and to explore its underlying mechanisms. Network pharmacology was employed to identify shared targets among ferroptosis, AKI‐CKD, and COR using multiple databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed, followed by molecular docking validation. In vivo, a renal unilateral ischemia–reperfusion (uIRI) mouse model was established in C57Bl/6N mice ( n = 20), randomly divided into four groups ( n = 5 each): Control, CKD model, COR, and CKD + COR. COR (10 mg/kg) or saline was administered intraperitoneally daily for 2 weeks. Renal pathology and fibrosis were assessed via H&E, PAS, and Masson staining; renal function by serum creatinine and proteinuria. In vitro, HK‐2 cells were treated with H 2 O 2 with or without COR, and cell viability was measured by CCK‐8. The Nrf2 inhibitor ML385 was used to verify pathway involvement. The mRNA and protein levels of GPX4, ACSL4, Nrf2, and Hmox1 were determined by qRT‐PCR and Western blot. Cross‐analysis of network pharmocology identified 42 common targets among 459 COR‐related, 843 AKI‐CKD‐related, and 1866 ferroptosis‐related genes. PPI network analysis suggested that TNF, IL6, and Hmox1 are key targets. Enrichment analyses indicated involvement in iron homeostasis and oxidative stress responses. Molecular docking revealed strong binding of COR to Nrf2 and Hmox1 (–8.5 and –6.7 kcal/mol). In vivo, model mice showed elevated serum creatinine and proteinuria, severe tubular damage, and increased fibrosis, all significantly ameliorated by COR. In vitro, H 2 O 2 reduced HK‐2 cell viability, downregulated GPX4, Nrf2, and Hmox1, and upregulated ACSL4; COR reversed these effects and improved cell survival. ML385 partially blocked COR's protective and regulatory effects, confirming Nrf2/Hmox1 pathway dependence. Our finding indicated that COR inhibits ferroptosis via activation of the Nrf2/Hmox1 signaling pathway, thereby attenuating renal injury and fibrosis and slowing AKI‐CKD progression.